EMAIL THIS PAGE TO A FRIEND

Neurological research

Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells.


PMID 24107416

Abstract

The incidence of Parkinson's disease (PD) is increasing as the global population ages. 6-hydroxydopamine (6-OHDA) can induce PD-like neuropathology and biochemical changes in both in vitro and in vivo models. Therefore, clarification of the molecular mechanism of 6-OHDA-induced cell death might contribute to the understanding of the pathogenesis of PD. With this goal in mind, we investigated the role of protein kinase C delta (PKC delta) in 6-OHDA-dependent death using the pheochromocytoma cell line, PC12. Cells were treated with 6-OHDA to induce toxicity with or without pretreatment using rottlerin (a PKC delta inhibitor), bisindolylmaleimide I (a general PKC inhibitor), Gö6976 (a PKC inhibitor selective for calcium-dependent PKC isoforms), or phorbol-12-myristate-13-acetate (PMA, a PKC activator). Phorbol-12-myristate-13-acetate decreased cell survival and increased the rate of apoptosis while rottlerin increased cell survival and decreased the rate of apoptosis. In contrast, neither bisindolylmaleimide I nor Gö6976 affected 6-OHDA-induced cell death. Western analysis demonstrated that phosphorylation of PKC delta on Thr 505 as well as extracellular signal-regulated kinase (ERK) phosphorylation increased after exposure to 6-OHDA. This increase in PKC delta phosphorylation was potentiated by PMA. However, rottlerin attenuated the 6-OHDA-stimulated increase in PKC delta and ERK phosphorylation. These data suggest that PKC delta, rather than classic-type PKC (alpha, beta1, beta2, gamma), participates in 6-OHDA-induced neurotoxicity in PC12 cells, and PKC delta activity is required for subsequent ERK activation during cell death.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300493
Anti-MAPK3 (Ab-202) antibody produced in rabbit, affinity isolated antibody
SAB4300494
Anti-MAPK3 (Ab-204) antibody produced in rabbit, affinity isolated antibody
GW22781 Anti-MAPK3 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1412386
ANTI-MAPK3 antibody produced in mouse, clone 1E2, purified immunoglobulin, buffered aqueous solution
SAB2701851
Anti-mapk3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701770
Anti-mapk3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA003995
Anti-MAPK3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA005700
Anti-MAPK3 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104574
Anti-MAPK3 antibody produced in rabbit, affinity isolated antibody
SAB2104732
Anti-MAPK3 antibody produced in rabbit, affinity isolated antibody
M3946 Anti-MNK1 antibody produced in rabbit, ~1.4 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4503422
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
SAB4503423
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
SAB4502389
Anti-p44 MAP Kinase antibody produced in rabbit, affinity isolated antibody
SAB4502390
Anti-p44 MAP Kinase antibody produced in rabbit, affinity isolated antibody
WH0005595M1
Monoclonal Anti-MAPK3 antibody produced in mouse, clone 3C9, purified immunoglobulin, buffered aqueous solution
SAB5300429
Monoclonal Anti-MAPK3 antibody produced in mouse, clone 1E5, ascites fluid
PLA0235
Rabbit anti-ERK1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.